Skip to contentBaker / Tisch Capital (GP), LLC — VIROPHARMA INC insider: 107 transactions · InsiderLensBaker / Tisch Capital (GP), LLC
- 10% owner at INCYTE CORP · on record since Dec 19, 2007
- 10% owner at VIROPHARMA INC · on record since Mar 1, 2006
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Dec 27, 2006
- 10% owner at ALLOS THERAPEUTICS INC · on record since Nov 17, 2006
- Director at GENOMIC HEALTH INC · on record since Dec 8, 2006
- Director at NEUROGEN CORP · on record since Oct 4, 2006
- 10% owner at NEUROGEN CORP · on record since Oct 4, 2006
- Director at TRIMERIS INC · on record since Oct 4, 2006
- 10% owner at TRIMERIS INC · on record since Oct 4, 2006
- 10% owner at GENOMIC HEALTH INC · on record since Feb 21, 2007
- Director at SEATTLE GENETICS INC /WA · on record since Feb 16, 2007
- 10% owner at SEATTLE GENETICS INC /WA · on record since Feb 16, 2007
- 10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Mar 11, 2010
- 10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 8, 2007
- 10% owner at ALTEON INC /DE · on record since Aug 3, 2007
- Director at INCYTE CORP · on record since Nov 21, 2007
- 10% owner at ADOLOR CORP · on record since Apr 28, 2010
- 10% owner at AP PHARMA INC /DE/ · on record since Oct 28, 2009
Insider trading activity of Baker / Tisch Capital (GP), LLC
- Transactions on record
- 107
- since Apr 21, 2004
- Open-market buys
- 67
- $273.2K
- Open-market sells
- 13
- $93.1K
- Companies traded
- 10
- last filing Jan 3, 2012
Figures computed from official regulatory filings — methodology.
Companies where Baker / Tisch Capital (GP), LLC has traded
Track record of Baker / Tisch Capital (GP), LLC
Statistical track record
Free- Open-market buys
- 86
- Last buy
- May 21, 2009
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Baker / Tisch Capital (GP), LLC
Co-insiders of Baker / Tisch Capital (GP), LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
1 tx · Apr 21, 2004
Baker Biotech Capital II (Z) (GP), LLCGENOMIC HEALTH INC +5
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jan 3, 2012 | Other | -12,679 | 4.25 USD | $53.9K | SEC |
| Jun 1, 2009 | Sell | -402 | 4.30 | $1.7K | SEC |
| Jun 1, 2009 | Sell | -2,157 | 3.86 | $8.3K | SEC |
| Jun 1, 2009 | Sell | -2,975 | 4.50 | $13.4K | SEC |
| Jun 1, 2009 | Sell | -835 | 3.89 | $3.2K | SEC |
| Jun 1, 2009 | Sell | -2,065 | 4.12 | $8.5K | SEC |
| Jun 1, 2009 | Sell | -1,651 | 4.45 | $7.3K | SEC |
| May 22, 2009 | Buy | 32 | 17.98 | $575.4 | SEC |
| May 22, 2009 | Buy | 10 | 17.82 | $178.2 | SEC |
| May 22, 2009 | Buy | 44 | 18.00 | $792 | SEC |
| May 22, 2009 | Buy | 4 | 17.88 | $71.5 | SEC |
| May 20, 2009 | Buy | 12 | 5.84 | $70.1 | SEC |
| May 20, 2009 | Buy | 110 | 6.00 | $660 | SEC |
| May 20, 2009 | Buy | 37 | 5.87 | $217.2 | SEC |
| May 20, 2009 | Buy | 73 | 5.98 | $436.5 | SEC |
| May 20, 2009 | Buy | 98 | 6.00 | $588 | SEC |
| May 20, 2009 | Buy | 52 | 5.99 | $311.5 | SEC |
| May 11, 2009 | Buy | 95 | 19.51 | $1.9K | SEC |
| May 11, 2009 | Buy | 32 | 19.53 | $625 | SEC |
| May 11, 2009 | Buy | 22 | 19.36 | $425.9 | SEC |
| May 11, 2009 | Buy | 67 | 19.67 | $1.3K | SEC |
| May 11, 2009 | Buy | 96 | 19.54 | $1.9K | SEC |
| Dec 19, 2008 | Buy | 93 | 3.60 | $334.8 | SEC |
| Dec 19, 2008 | Buy | 543 | 3.33 | $1.8K | SEC |
| Dec 19, 2008 | Buy | 1,535 | 3.56 | $5.5K | SEC |